DD290186A5 - Verfahren zur herstellung von piperidinderivaten - Google Patents
Verfahren zur herstellung von piperidinderivaten Download PDFInfo
- Publication number
- DD290186A5 DD290186A5 DD89335505A DD33550589A DD290186A5 DD 290186 A5 DD290186 A5 DD 290186A5 DD 89335505 A DD89335505 A DD 89335505A DD 33550589 A DD33550589 A DD 33550589A DD 290186 A5 DD290186 A5 DD 290186A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- hydrogen
- hydroxy
- formula
- alkyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH457488 | 1988-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD290186A5 true DD290186A5 (de) | 1991-05-23 |
Family
ID=4278632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD89335505A DD290186A5 (de) | 1988-12-12 | 1989-12-11 | Verfahren zur herstellung von piperidinderivaten |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0374095A3 (da) |
| JP (1) | JPH02212471A (da) |
| AU (1) | AU4607689A (da) |
| CA (1) | CA2004986A1 (da) |
| DD (1) | DD290186A5 (da) |
| DK (1) | DK623689A (da) |
| FI (1) | FI895882A7 (da) |
| HU (1) | HUT53078A (da) |
| IL (1) | IL92633A0 (da) |
| PT (1) | PT92536A (da) |
| YU (1) | YU233489A (da) |
| ZA (1) | ZA899436B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8904298D0 (sv) * | 1989-12-21 | 1989-12-21 | Astra Ab | New compounds |
| CA2047389C (en) * | 1990-07-24 | 2002-04-23 | James R. Mccarthy | Substituted piperidines and their use as inhibitors of cholesterol synthesis |
| GB9319534D0 (en) * | 1993-09-22 | 1993-11-10 | Boots Co Plc | Therapeutic agents |
| SE9404438D0 (sv) * | 1994-12-21 | 1994-12-21 | Astra Ab | New process |
| US5661163A (en) * | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
| GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| IL154107A0 (en) * | 2000-07-26 | 2003-07-31 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| WO2003064421A1 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine derivatives |
| AU2003239302A1 (en) | 2002-01-29 | 2003-09-02 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
| MX363734B (es) * | 2011-10-27 | 2019-03-29 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166132A (en) * | 1977-08-18 | 1979-08-28 | Pfizer Inc. | Antiviral amine derivatives of glycerol and propanediols |
| US4173641A (en) * | 1978-05-15 | 1979-11-06 | Pfizer Inc. | Di-O-n-alkyl glycerol derivatives as immune stimulants |
| DE3225733A1 (de) * | 1982-07-09 | 1984-01-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue, durch ether- und thioetherreste n-substituierte piperidine und piperazine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
-
1989
- 1989-12-01 ZA ZA899436A patent/ZA899436B/xx unknown
- 1989-12-05 EP EP19890810919 patent/EP0374095A3/de not_active Withdrawn
- 1989-12-08 CA CA002004986A patent/CA2004986A1/en not_active Abandoned
- 1989-12-08 AU AU46076/89A patent/AU4607689A/en not_active Abandoned
- 1989-12-08 FI FI895882A patent/FI895882A7/fi not_active Application Discontinuation
- 1989-12-11 IL IL92633A patent/IL92633A0/xx unknown
- 1989-12-11 PT PT92536A patent/PT92536A/pt not_active Application Discontinuation
- 1989-12-11 DD DD89335505A patent/DD290186A5/de not_active IP Right Cessation
- 1989-12-11 JP JP1319055A patent/JPH02212471A/ja active Pending
- 1989-12-11 HU HU896499A patent/HUT53078A/hu unknown
- 1989-12-11 YU YU02334/89A patent/YU233489A/xx unknown
- 1989-12-11 DK DK623689A patent/DK623689A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HU896499D0 (en) | 1990-02-28 |
| CA2004986A1 (en) | 1990-06-12 |
| JPH02212471A (ja) | 1990-08-23 |
| ZA899436B (en) | 1990-08-29 |
| FI895882A0 (fi) | 1989-12-08 |
| DK623689D0 (da) | 1989-12-11 |
| PT92536A (pt) | 1990-06-29 |
| AU4607689A (en) | 1990-06-14 |
| FI895882A7 (fi) | 1990-06-13 |
| EP0374095A3 (de) | 1991-10-30 |
| HUT53078A (en) | 1990-09-28 |
| DK623689A (da) | 1990-06-13 |
| IL92633A0 (en) | 1990-08-31 |
| YU233489A (en) | 1991-02-28 |
| EP0374095A2 (de) | 1990-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT363096B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen | |
| DE3852288T2 (de) | K-252-Derivate mit Antitumorwirkung und diese enthaltende Arzneimittel. | |
| DD290186A5 (de) | Verfahren zur herstellung von piperidinderivaten | |
| DE60300021T2 (de) | que- | |
| DE3814504A1 (de) | (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| EP0135762B1 (de) | Steroide | |
| DE69626981T2 (de) | N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide | |
| DE2424119A1 (de) | Mycophenolsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| EP0495750A2 (de) | Heterozyklische Hydroxylamine | |
| DE69612753T2 (de) | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung | |
| DE69126978T2 (de) | Derivate des 6-amino-octahydro-indolizintriols | |
| DD223452A5 (de) | Verfahren zur herstellung von piperidinochinazolinen | |
| DE69718968T2 (de) | 3-(bis-substituierte-phenylmethylen)oxindol-derivate | |
| EP0254955B1 (de) | Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2930608C2 (de) | Alkylthiophenoxyalkylamine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| EP0369944A1 (de) | Substituierte Oxadiaminobutane | |
| DE69622415T2 (de) | 12H-Dibenzo[d,g][1,3]dioxocin Derivate | |
| EP0085893B1 (de) | Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2427272C3 (de) | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum | |
| DE69910542T2 (de) | Hydroxamsäure- und carbonsäurederivative | |
| DD213216A5 (de) | Verfahren zur herstellung eines neuen pynolidin-derivates | |
| DD275689A5 (de) | Verfahren zur herstellung von enolethern von 6-chlor-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazin-3-carbonsaeureamid-1,1-dioxid | |
| EP0388739A1 (de) | Tetrahydronaphtalinderivate | |
| EP0086980B1 (de) | Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE60007748T2 (de) | Benzimidazolderivate und sie enthaltende medikamente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |